Prostate Cancer Pipeline Review, 2015
Summary
GlobalData's Medical Devices sector report, Prostate Cancer Pipeline Review, 2015 provides an overview of Prostate Cancer diagnostic tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer diagnostic tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Prostate Cancer diagnostic tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Prostate Cancer diagnostic tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R & D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Prostate Cancer diagnostic tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the products current stage of development, territory and estimated launch date
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 20
2 Introduction 21
2.1 Prostate Cancer Overview 21
3 Products under Development 22
3.1 Prostate Cancer - Pipeline Products by Stage of Development 22
3.2 Prostate Cancer - Pipeline Products by Territory 23
3.3 Prostate Cancer - Pipeline Products by Regulatory Path 24
3.4 Prostate Cancer - Pipeline Products by Estimated Approval Date 25
3.5 Prostate Cancer - Ongoing Clinical Trials 26
4 Prostate Cancer - Pipeline Products under Development by Companies 27
4.1 Prostate Cancer Companies - Pipeline Products by Stage of Development 27
4.2 Prostate Cancer - Pipeline Products by Stage of Development 33
5 Prostate Cancer Companies and Product Overview 40
5.1 3D Biomatrix, LLC Company Overview 40
5.2 A&G Pharmaceutical, Inc. Company Overview 41
5.3 Abbott Diagnostics Company Overview 42
5.4 Abnova Corporation Company Overview 43
5.5 AccuTech, LLC Company Overview 45
5.6 Advanced Marker Discovery, S.L. Company Overview 46
5.7 Affinimark Technologies, Inc. Company Overview 47
5.8 Almac Diagnostics Limited Company Overview 48
5.9 AltheaDx, Inc. Company Overview 50
5.10 Ambrilia Biopharma Inc. Company Overview 51
5.11 Andro Diagnostics Company Overview 52
5.12 Arno Therapeutics, Inc. Company Overview 53
5.13 AroCell AB Company Overview 55
5.14 Arrayit Diagnostics, Inc. Company Overview 56
5.15 Aurelium BioPharma Inc. (Inactive) Company Overview 57
5.16 Bayer HealthCare AG Company Overview 58
5.17 Baylor College of Medicine Company Overview 60
5.18 Beckman Coulter, Inc. Company Overview 61
5.19 Biocare Medical LLC Company Overview 63
5.20 Biocept, Inc. Company Overview 64
5.21 Biocrates Life Sciences AG Company Overview 66
5.22 BioMark Diagnostics Inc. Company Overview 67
5.23 BioMark Technologies Inc. Company Overview 68
5.24 bioMerieux S.A. Company Overview 69
5.25 Biomoda, Inc. (Inactive) Company Overview 74
5.26 BioRap Technologies Ltd. Company Overview 75
5.27 Biosceptre (Aust) Pty Ltd Company Overview 76
5.28 Biotron Limited Company Overview 77
5.29 Blondin Bioscience, LLC Company Overview 79
5.30 Caldera Health Limited Company Overview 80
5.31 Cancer Genetics, Inc. Company Overview 81
5.32 Cancer Research Technology Limited Company Overview 83
5.33 Caprion Inc. Company Overview 84
5.34 Caris Life Sciences, Inc. Company Overview 85
5.35 Cellanyx Diagnostics, Inc. Company Overview 86
5.36 CellMax Life Company Overview 89
5.37 Cellmid Limited Company Overview 90
5.38 Cepheid Company Overview 92
5.39 Ceres Nanosciences, Inc. Company Overview 94
5.40 ChemImage Corporation Company Overview 95
5.41 China Sky One Medical, Inc. Company Overview 96
5.42 Chronix Biomedical, Inc. Company Overview 98
5.43 Cleveland Diagnostics Inc. Company Overview 99
5.44 CompanDX Ltd. Company Overview 100
5.45 Courtagen Life Sciences, Inc. Company Overview 101
5.46 CS-Keys, Inc. Company Overview 102
5.47 Cytosystems Ltd Company Overview 103
5.48 Dartmouth College Company Overview 105
5.49 Detroit R&D, Inc. Company Overview 107
5.50 Diaxonhit S.A. Company Overview 108
5.51 Egenix, Inc. Company Overview 109
5.52 Epigenomics AG Company Overview 110
5.53 Euclid Diagnostics LLC Company Overview 114
5.54 Eventus Diagnostics, Inc. Company Overview 115
5.55 Exiqon A/S Company Overview 116
5.56 Exosome Diagnostics, Inc. Company Overview 121
5.57 Exosomics Siena SpA Company Overview 125
5.58 Fluxion Biosciences, Inc. Company Overview 126
5.59 Gene Probe, Inc. Company Overview 128
5.60 GeneFluidics Inc. Company Overview 129
5.61 GeneNews Limited Company Overview 131
5.62 Genomic Health, Inc. Company Overview 133
5.63 Georgia Institute of Technology Company Overview 136
5.64 GILUPI Nanomedizin Company Overview 137
5.65 GlycoZym Company Overview 138
5.66 Health Discovery Corporation Company Overview 139
5.67 Hologic, Inc. Company Overview 140
5.68 Ikonisys, Inc. Company Overview 142
5.69 Imperial College London Company Overview 143
5.70 Inanovate (UK) Ltd. Company Overview 144
5.71 Institut National de la Sante et de la Recherche Medicale Company Overview 145
5.72 InterGenetics Incorporated Company Overview 146
5.73 IRIS International, Inc. Company Overview 147
5.74 IV Diagnostics, Inc. Company Overview 149
5.75 KineMed, Inc. Company Overview 150
5.76 MabCure Inc. Company Overview 151
5.77 MacroArray Technologies, LLC. Company Overview 153
5.78 Matritech, Inc. (Inactive) Company Overview 156
5.79 Mayo Clinic Company Overview 157
5.80 MDNA Life Sciences, Inc. Company Overview 158
5.81 MDxHealth SA Company Overview 159
5.82 Metabolomic Technologies Inc. Company Overview 161
5.83 Metabolon, Inc. Company Overview 162
5.84 Metanomics Health GmbH Company Overview 163
5.85 MetaStat, Inc. Company Overview 164
5.86 Milagen, Inc. Company Overview 166
5.87 Minomic International Ltd Company Overview 167
5.88 Miraculins Inc. Company Overview 170
5.89 Nano Discovery Inc. Company Overview 172
5.90 Neogenix Oncology, Inc. Company Overview 174
5.91 NeoGenomics, Inc. Company Overview 175
5.92 NeuroBioTex Inc. Company Overview 177
5.93 Novel Bio-spectrum Technologies, Inc. Company Overview 178
5.94 NovioGendix Holding B.V Company Overview 179
5.95 Nuclea Biotechnologies Inc. Company Overview 180
5.96 Numares GmbH Company Overview 182
5.97 NuView Life Sciences, Inc. Company Overview 183
5.98 Onconome, Inc. Company Overview 186
5.99 ONCOVEDA Cancer Research Center Company Overview 188
5.100 OncoVista Innovative Therapies, Inc. Company Overview 189
5.101 On-Q-ity, Inc. (Inactive) Company Overview 191
5.102 OPKO Health, Inc. Company Overview 192
5.103 Orion Genomics LLC Company Overview 194
5.104 Ortho-Clinical Diagnostics Inc. Company Overview 195
5.105 Oryzon Genomics S.A. Company Overview 196
5.106 OTraces Inc. Company Overview 197
5.107 Oxford Gene Technology Limited Company Overview 198
5.108 Panacea Pharmaceuticals, Inc. Company Overview 200
5.109 PharmaSeq, Inc. Company Overview 201
5.110 Predictive Biosciences, Inc. Company Overview 202
5.111 PrognosDx Health, Inc. Company Overview 204
5.112 Prostate Management Diagnostics, Inc Company Overview 205
5.113 Protagen AG Company Overview 207
5.114 Proteocyte Diagnostics Inc Company Overview 208
5.115 ProteoMediX AG Company Overview 209
5.116 Proteomika Company Overview 213
5.117 Proveri Inc. Company Overview 214
5.118 Qiagen N.V. Company Overview 218
5.119 Quanterix Corporation Company Overview 220
5.120 RiboMed Biotechnologies, Inc. Company Overview 223
5.121 Rice University Company Overview 224
5.122 Roche Diagnostics International Ltd. Company Overview 225
5.123 Roswell Park Cancer Institute Company Overview 228
5.124 Siamab Therapeutics, Inc. Company Overview 229
5.125 Siemens Healthcare Diagnostics Inc. Company Overview 230
5.126 Sienna Cancer Diagnostics Ltd Company Overview 235
5.127 Sividon Diagnostics GmbH Company Overview 236
5.128 Skuldtech France Company Overview 237
5.129 Soricimed Biopharma Inc. Company Overview 238
5.130 Source MDx Company Overview 240
5.131 Stage I Diagnostics, Inc. Company Overview 242
5.132 Target Discovery, Inc. Company Overview 243
5.133 The Johns Hopkins University Company Overview 244
5.134 Transbiomed, SL Company Overview 251
5.135 True Diagnostics, Inc. Company Overview 254
5.136 Tyrian Diagnostics Limited Company Overview 255
5.137 Universite De Lyon Company Overview 258
5.138 University of California, Los Angeles Company Overview 259
5.139 University of Central Florida Company Overview 261
5.140 University of Chicago Company Overview 262
5.141 University of Colorado Company Overview 264
5.142 University of Gottingen Company Overview 265
5.143 University of Oslo Company Overview 266
5.144 University of Otago Company Overview 267
5.145 University of Pittsburgh Company Overview 268
5.146 University of South Australia Company Overview 269
5.147 University of South Florida Company Overview 270
5.148 University of Strathclyde Company Overview 271
5.149 Uppsala County Council Company Overview 272
5.150 UroSens Ltd Company Overview 273
5.151 US Biomarkers, Inc. Company Overview 274
5.152 Vermillion, Inc. Company Overview 275
5.153 Vitatex Inc. Company Overview 278
5.154 Vitrimark, Inc. Company Overview 280
5.155 Vitruvian Biomedical, Inc. Company Overview 281
5.156 VolitionRX Ltd. Company Overview 282
5.157 ZEUS Scientific, Inc. Company Overview 286
6 Prostate Cancer- Recent Developments 287
7 Appendix 347
7.1 Methodology 347
7.2 About GlobalData 349
7.3 Contact Us 350
7.4 Disclaimer 350
List Of Tables
1.1 List of Tables
Table 1: Prostate Cancer - Pipeline Products by Stage of Development 25
Table 2: Prostate Cancer - Pipeline Products by Territory 26
Table 3: Prostate Cancer - Pipeline Products by Regulatory Path 27
Table 4: Prostate Cancer - Pipeline Products by Estimated Approval Date 28
Table 5: Prostate Cancer - Ongoing Clinical Trials 29
Table 6: Prostate Cancer Companies - Pipeline Products by Stage of Development 30
Table 7: Prostate Cancer - Pipeline Products by Stage of Development 36
Table 8: 3D Biomatrix, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
Table 9: 3D Cell Assay - Metastatic Prostate Cancer - Product Status 43
Table 10: 3D Cell Assay - Metastatic Prostate Cancer - Product Description 43
Table 11: A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 12: Companion Diagnostic Test - Prostate Cancer - Product Status 44
Table 13: Companion Diagnostic Test - Prostate Cancer - Product Description 44
Table 14: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 45
Table 15: ERG Companion Diagnostic Assay - Product Status 45
Table 16: ERG Companion Diagnostic Assay - Product Description 45
Table 17: Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
Table 18: Biomarker Test - Prostate Cancer - Product Status 47
Table 19: Biomarker Test - Prostate Cancer - Product Description 47
Table 20: AccuTech, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Table 21: PSA Test - Product Status 48
Table 22: PSA Test - Product Description 48
Table 23: Advanced Marker Discovery, S.L. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 24: Urine Based Diagnostic Test - Prostate Cancer - Product Status 49
Table 25: Urine Based Diagnostic Test - Prostate Cancer - Product Description 49
Table 26: Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 27: Prostalent Diagnostic Test - Product Status 50
Table 28: Prostalent Diagnostic Test - Product Description 50
Table 29: Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 51
Table 30: Prognostic Test - Metastatic Prostate Cancer - Product Status 52
Table 31: Prognostic Test - Metastatic Prostate Cancer - Product Description 52
Table 32: AltheaDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 33: Prognostic Assay - Prostate Cancer - Product Status 53
Table 34: Prognostic Assay - Prostate Cancer - Product Description 53
Table 35: Ambrilia Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
Table 36: PSP94 Immunoassay - Product Status 54
Table 37: PSP94 Immunoassay - Product Description 54
Table 38: Andro Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 55
Table 39: Diagnostic Test - Prostate Cancer - Product Status 55
Table 40: Diagnostic Test - Prostate Cancer - Product Description 55
Table 41: Arno Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
Table 42: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Status 57
Table 43: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Description 57
Table 44: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 58
Table 45: TK 210 Assay - Prostate Cancer - Product Status 58
Table 46: TK 210 Assay - Prostate Cancer - Product Description 58
Table 47: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 48: Microarray-Based Diagnostic Test - Prostate Cancer - Product Status 59
Table 49: Microarray-Based Diagnostic Test - Prostate Cancer - Product Description 59
Table 50: Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 60
Table 51: Prostate Cancer Screening Test - Product Status 60
Table 52: Prostate Cancer Screening Test - Product Description 60
Table 53: Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview 61
Table 54: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Status 62
Table 55: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Description 62
Table 56: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 63
Table 57: Diagnostic Assay - Prostate Cancer - Product Status 63
Table 58: Diagnostic Assay - Prostate Cancer - Product Description 63
Table 59: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 60: Diagnostic Test - Prostate Cancer - Product Status 64
Table 61: Diagnostic Test - Prostate Cancer - Product Description 64
Table 62: UniCel DxC 600i Synchron Access BPH-A Assay - Product Status 65
Table 63: UniCel DxC 600i Synchron Access BPH-A Assay - Product Description 65
Table 64: Biocare Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 66
Table 65: Clear View - Prostate Cancer - Product Status 66
Table 66: Clear View - Prostate Cancer - Product Description 66
Table 67: Biocept, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 68: OncoCEE-PR - Product Status 68
Table 69: OncoCEE-PR - Product Description 68
Table 70: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview 69
Table 71: Metabolomic Biomarker Assay - Prostate Cancer - Product Status 69
Table 72: Metabolomic Biomarker Assay - Prostate Cancer - Product Description 69
Table 73: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 74: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Status 70
Table 75: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Description 70
Table 76: BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 77: Biomarker Assay - Prostate Cancer - Product Status 71
Table 78: Biomarker Assay - Prostate Cancer - Product Description 71
Table 79: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 80: Annexin A3 Prostate Cancer Marker - Product Status 73
Table 81: Annexin A3 Prostate Cancer Marker - Product Description 73
Table 82: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status 74
Table 83: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description 74
Table 84: Diagnostic Assay - Prostate Cancer - Product Status 75
Table 85: Diagnostic Assay - Prostate Cancer - Product Description 75
Table 86: Screening Biomarker Assay - Prostate Cancer - Product Status 76
Table 87: Screening Biomarker Assay - Prostate Cancer - Product Description 76
Table 88: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 77
Table 89: CyPath Diagnostic Assay - Prostate Cancer - Product Status 77
Table 90: CyPath Diagnostic Assay - Prostate Cancer - Product Description 77
Table 91: BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 92: Biomarker Test - Prostate Cancer - Product Status 78
Table 93: Biomarker Test - Prostate Cancer - Product Description 78
Table 94: Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 79
Table 95: Prostate Cancer IHC Diagnostic Test - Product Status 79
Table 96: Prostate Cancer IHC Diagnostic Test - Product Description 79
Table 97: Biotron Limited Pipeline Products & Ongoing Clinical Trials Overview 80
Table 98: C-Test - Prostrate Cancer - Product Status 81
Table 99: C-Test - Prostrate Cancer - Product Description 81
Table 100: Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 82
Table 101: FACT Assay - Product Status 82
Table 102: FACT Assay - Product Description 82
Table 103: Caldera Health Limited Pipeline Products & Ongoing Clinical Trials Overview 83
Table 104: ProscaNZ - Product Status 83
Table 105: ProscaNZ - Product Description 83
Table 106: Cancer Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
Table 107: Next-Gen DNA Sequencing Assay - Prostate Cancer - Product Status 85
Table 108: Next-Gen DNA Sequencing Assay - Prostate Cancer - Product Description 85
Table 109: Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 86
Table 110: IHC Based Test - Prostate Cancer - Product Status 86
Table 111: IHC Based Test - Prostate Cancer - Product Description 86
Table 112: Caprion Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
Table 113: Diagnostic Assay - Prostate Cancer - Product Status 87
Table 114: Diagnostic Assay - Prostate Cancer - Product Description 87
Table 115: Caris Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
Table 116: Diagnostic Test - PSA - Product Status 88
Table 117: Diagnostic Test - PSA - Product Description 88
Table 118: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
Table 119: Cellanyx Test - Prostate Cancer - Product Status 89
Table 120: Cellanyx Test - Prostate Cancer - Product Description 89
Table 121: Cellanyx Diagnostics, Inc. - Ongoing Clinical Trials Overview 90
Table 122: Cellanyx Test - Prostate Cancer - A Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers with Objective Algorithmic Analysis for Prostate Cancer Risk Stratification 91
Table 123: CellMax Life Pipeline Products & Ongoing Clinical Trials Overview 92
Table 124: Diagnostic Assay - Prostate Cancer - Product Status 92
Table 125: Diagnostic Assay - Prostate Cancer - Product Description 92
Table 126: Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview 93
List Of Figures
1.2 List of Figures
Figure 1: Prostate Cancer - Pipeline Products by Stage of Development 25
Figure 2: Prostate Cancer - Pipeline Products by Territory 26
Figure 3: Prostate Cancer - Pipeline Products by Regulatory Path 27
Figure 4: Prostate Cancer - Pipeline Products by Estimated Approval Date 28
Figure 5: Prostate Cancer - Ongoing Clinical Trials 29
